Literature DB >> 29028943

A joint model for mixed and truncated longitudinal data and survival data, with application to HIV vaccine studies.

Tingting Yu1, Lang Wu1, Peter B Gilbert2.   

Abstract

In HIV vaccine studies, a major research objective is to identify immune response biomarkers measured longitudinally that may be associated with risk of HIV infection. This objective can be assessed via joint modeling of longitudinal and survival data. Joint models for HIV vaccine data are complicated by the following issues: (i) left truncations of some longitudinal data due to lower limits of quantification; (ii) mixed types of longitudinal variables; (iii) measurement errors and missing values in longitudinal measurements; (iv) computational challenges associated with likelihood inference. In this article, we propose a joint model of complex longitudinal and survival data and a computationally efficient method for approximate likelihood inference to address the foregoing issues simultaneously. In particular, our model does not make unverifiable distributional assumptions for truncated values, which is different from methods commonly used in the literature. The parameters are estimated based on the h-likelihood method, which is computationally efficient and offers approximate likelihood inference. Moreover, we propose a new approach to estimate the standard errors of the h-likelihood based parameter estimates by using an adaptive Gauss-Hermite method. Simulation studies show that our methods perform well and are computationally efficient. A comprehensive data analysis is also presented.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29028943      PMCID: PMC6193623          DOI: 10.1093/biostatistics/kxx047

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  14 in total

1.  Maximum likelihood estimation for longitudinal data with truncated observations.

Authors:  K G Mehrotra; P M Kulkarni; R C Tripathi; J E Michalek
Journal:  Stat Med       Date:  2000-11-15       Impact factor: 2.373

2.  Mixed effects models with censored data with application to HIV RNA levels.

Authors:  J P Hughes
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

3.  Joint modeling of survival and longitudinal data: likelihood approach revisited.

Authors:  Fushing Hsieh; Yi-Kuan Tseng; Jane-Ling Wang
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

4.  A joint model for survival and longitudinal data measured with error.

Authors:  M S Wulfsohn; A A Tsiatis
Journal:  Biometrics       Date:  1997-03       Impact factor: 2.571

5.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

6.  Real-time individual predictions of prostate cancer recurrence using joint models.

Authors:  Jeremy M G Taylor; Yongseok Park; Donna P Ankerst; Cecile Proust-Lima; Scott Williams; Larry Kestin; Kyoungwha Bae; Tom Pickles; Howard Sandler
Journal:  Biometrics       Date:  2013-02-04       Impact factor: 2.571

7.  Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariates.

Authors:  Qingxia Chen; Ryan C May; Joseph G Ibrahim; Haitao Chu; Stephen R Cole
Journal:  Stat Med       Date:  2014-06-20       Impact factor: 2.373

8.  Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling.

Authors:  Rong Fu; Peter B Gilbert
Journal:  Lifetime Data Anal       Date:  2016-03-23       Impact factor: 1.588

Review 9.  Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.

Authors:  A Lawrence Gould; Mark Ernest Boye; Michael J Crowther; Joseph G Ibrahim; George Quartey; Sandrine Micallef; Frederic Y Bois
Journal:  Stat Med       Date:  2014-03-14       Impact factor: 2.373

10.  Joint modelling of repeated measurements and time-to-event outcomes: flexible model specification and exact likelihood inference.

Authors:  Jessica Barrett; Peter Diggle; Robin Henderson; David Taylor-Robinson
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2014-04-08       Impact factor: 4.488

View more
  3 in total

Review 1.  New approaches for censored longitudinal data in joint modelling of longitudinal and survival data, with application to HIV vaccine studies.

Authors:  Tingting Yu; Lang Wu; Peter Gilbert
Journal:  Lifetime Data Anal       Date:  2018-06-08       Impact factor: 1.588

2.  Nonlinear mixed-effects models for HIV viral load trajectories before and after antiretroviral therapy interruption, incorporating left censoring.

Authors:  Sihaoyu Gao; Lang Wu; Tingting Yu; Roger Kouyos; Huldrych F Günthard; Rui Wang
Journal:  Stat Commun Infect Dis       Date:  2022-04-04

3.  Estimation of time of HIV seroconversion using a modified CD4 depletion model.

Authors:  Viviane D Lima; Lu Wang; Paul Sereda; Taylor McLinden; Rolando Barrios; Julio S G Montaner
Journal:  PLoS One       Date:  2021-02-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.